job title:Clinical Research - Earn for Participation
QR Code Link to This Post
Autoimmune Hemolytic Anemia (AIHA) is a rare condition in which the body’s immune system mistakenly attacks and destroys its own red blood cells, leading to anemia. Because red blood cells are destroyed faster than they can be replaced, people with AIHA may experience fatigue, weakness, shortness of breath, pale or yellowish skin, dark urine, and an enlarged spleen. AIHA can occur on its own (primary) or in connection with other conditions such as autoimmune diseases, infections, certain cancers, or as a reaction to medications. There are two main types: warm AIHA, where antibodies attack red blood cells at body temperature, and cold AIHA, where antibodies become active in colder temperatures. Treatment depends on severity and underlying cause, and may include medications to suppress the immune system, blood transfusions, or treatment of the associated condition.
We are currently seeking volunteers for a clinical study evaluating the safety and effectiveness of a potential treatment for Autoimmune Hemolytic Anemia (AIHA).
If you or someone you know may be interested, please reach out to learn more about eligibility and the potential benefits of participation.
To qualify:
●Participants must be 18 years of age or older
●Men and women diagnosed with primary Autoimmune Hemolytic Anemia (AIHA) for at least 3 months
●Female participants must not be pregnant or breastfeeding
Qualified participants will receive:
●up to $100 per clinic visit with no cost to you or your insurance!
●Regular check-ins and assessments to ensure your health is a priority.